IRIS

Sfoglia per Autore  VACCA, GIOVANNI

Opzioni
Mostrati risultati da 1 a 11 di 11
Titolo Tipologia Data di pubblicazione Autore(i) File
Endothelin-1 serum levels are increased in patients with multiple sclerosis. 1.5 Abstract in rivista 2015 Criscuolo, C; Lanzillo, Roberta; Cianflone, Alessandra; Postiglione, E; Liuzzi, R; Vacca, Giovanni; Moccia, Marcello; BRESCIA MORRA, Vincenzo
Anti-JC virus antibodies index and JCV DNA concordance and markers of active viral replication: true exposure to JCV virus in natalizumab treated patients. In MULTIPLE SCLEROSIS JOURNAL (Vol. 19, No. 11, pp. 495-496). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. 1.5 Abstract in rivista 2013 Lanzillo, Roberta; Liuzzi, R; Vallefuoco, Luca; Amato, L; Vacca, Giovanni; Vacchiano, V; BRESCIA MORRA, Vincenzo
JCV antibodies index on natalizumab treatment: fluctuations and seroconversion. 1.5 Abstract in rivista 2013 Lanzillo, Roberta; Amato, L; Vacchiano, V; Moccia, Marcello; Vacca, Giovanni; BRESCIA MORRA, Vincenzo
JCV antibodies seroconversion on natalizumab treatment and predictive factors: preliminary data. 1.5 Abstract in rivista 2012 Lanzillo, Roberta; Liuzzi, R; Guacci, A; Amato, L; Vallefuoco, Luca; Vacca, Giovanni; BRESCIA MORRA, Vincenzo
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 1.5 Abstract in rivista 2009 Lanzillo, Roberta; Di Somma, Mc; Quarantelli, M; Ventrella, G; Prinster, A; Vacca, Giovanni; Orefice, Giuseppe; Colao, A. M; BRESCIA MORRA, Vincenzo
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 1.5 Abstract in rivista 2009 Quarantelli, M; Lanzillo, Roberta; Prinster, A; Mollica, C; Orefice, G; Brunetti, A; Vacca, Giovanni; Salvatore, M; BRESCIA MORRA, Vincenzo
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 1.5 Abstract in rivista 2009 Lanzillo, Roberta; Di Somma, C; Quarantelli, M; Ventrella, G; Prinster, A; Vacca, Giovanni; Orefice, Giuseppe; Colao, Annamaria; BRESCIA MORRA, Vincenzo
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 1.5 Abstract in rivista 2008 BRESCIA MORRA, Vincenzo; Prinster, A; Lanzillo, Roberta; Quarantelli, M; Vacca, Giovanni; Mollica, C; Schiavone, V; Brunetti, A; Salvatore, Elena; Alfano, B; Orefice, Giuseppe
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 1.5 Abstract in rivista 2007 Orefice, Giuseppe; Quarantelli, M; Salvatore, P; Brunetti, A; Lanzillo, Roberta; Prinster, Anna; Vacca, Giovanni; Mollica, C; Bonavita, Vincenzo; Morra, Vb
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 1.5 Abstract in rivista 2005 BRESCIA MORRA, Vincenzo; Lanzillo, Roberta; Pagano, A; Vacca, Giovanni; Longobardi, R; Schiavone, V; Orefice, Giuseppe
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 1.1 Articolo in rivista 2002 Orefice, Giuseppe; Brancaccio, V; Coppola, G; Iannaccone, L; Ascione, S; Manchia, A; Vacca, Giovanni; BRESCIA MORRA, Vincenzo
Mostrati risultati da 1 a 11 di 11
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile